Response to life-threatening anaphylaxis to venom immunotherapy in a patient taking an angiotensin-converting enzyme inhibitor

Response to life-threatening anaphylaxis to venom immunotherapy in a patient taking an angiotensin-converting enzyme inhibitor

The authors imply that patients with venom allergy who are receiving venom immunotherapy (VIT) while taking and angiotensin-converting enzyme inhibitor (ACEI) are at increased risk of severe anaphylaxis compared with those receiving specific immunotherapy (SIT) for environmental allergens while taki...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2004-06, Vol.113 (6), p.1224-1224
1. Verfasser: Melamed, Julian
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Anaphylaxis - etiology
Angiotensin-Converting Enzyme Inhibitors - adverse effects
Drug therapy
Enzymes
Humans
Immunotherapy - adverse effects
Patients
Venom
Venoms - therapeutic use
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The authors imply that patients with venom allergy who are receiving venom immunotherapy (VIT) while taking and angiotensin-converting enzyme inhibitor (ACEI) are at increased risk of severe anaphylaxis compared with those receiving specific immunotherapy (SIT) for environmental allergens while taking an ACEI.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2004.01.774